Cited by 192Cardiac electrophysiology and arrhythmiasAtrial Fibrillation Management and OutcomesGenomics and Rare Diseases

The DOI matches its Crossref record; 49 of the 51 references it cites were found in a registry or an index.

Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes

Open access

Yoneda, Zachary T., Anderson, Katherine C., Quintana, Joseph A., O’Neill, Matthew J., Sims, Richard A., Glazer, Andrew M., Shaffer, Christian M., Crawford, Diane M., Stricker, Thomas, Ye, Fei, Wells, Quinn, Stevenson, Lynne W., Michaud, Gregory F., Darbar, Dawood, Lubitz, Steven A., Ellinor, Patrick T., Roden, Dan M., Shoemaker, M. Benjamin·2021·JAMA Cardiology

DOI 10.1001/jamacardio.2021.3370PMC PMC8427496

Open this paper in CoChat — free account Open PDF

Abstract

Importance: Early-onset atrial fibrillation (AF) can be the initial manifestation of a more serious underlying inherited cardiomyopathy or arrhythmia syndrome. Objective: To examine the results of genetic testing for early-onset AF. Design, Setting, and Participants: This prospective, observational cohort study enrolled participants from an academic medical center who had AF diagnosed before 66 years of age and underwent whole genome sequencing through the National Heart, Lung, and Blood Institute's Trans-Omics for Precision Medicine program. Participants were enrolled from November 23, 1999, to June 2, 2015. Data analysis was performed from October 24, 2020, to March 11, 2021. Exposures: Rare variants identified in a panel of 145 genes that are included on cardiomyopathy and arrhythmia panels used by commercial clinical genetic testing laboratories. Main Outcomes and Measures: Sequencing data were analyzed using an automated process followed by manual review by a panel of independent, blinded reviewers. The primary outcome was classification of rare variants using American College of Medical Genetics and Genomics criteria: benign, likely benign, variant of undetermined significance, likely pathogenic, or pathogenic. Disease-associated variants were defined as pathogenic/likely pathogenic variants in genes associated with autosomal dominant or X-linked dominant disorders. Results: Among 1293 participants (934 [72.2%] male; median [interquartile range] age at enrollment, 56 [48-61] years; median [interquartile range] age at AF diagnosis, 50 [41-56] years), genetic testing identified 131 participants (10.1%) with a disease-associated variant, 812 (62.8%) with a variant of undetermined significance, 92 (7.1%) as heterozygous carriers for an autosomal recessive disorder, and 258 (20.0%) with no suspicious variant. The likelihood of a disease-associated variant was highest in participants with AF diagnosed before the age of 30 years (20 of 119 [16.8%; 95% CI, 10.0%-23.6%]) and lowest after the age of 60 years (8 of 112 [7.1%; 95% CI, 2.4%-11.9%]). Disease-associated variants were more often associated with inherited cardiomyopathy syndromes compared with inherited arrhythmias. The most common genes were TTN (n = 38), MYH7 (n = 18), MYH6 (n = 10), LMNA (n = 9), and KCNQ1 (n = 8). Conclusions and Relevance: In this cohort study, genetic testing identified a disease-associated variant in 10% of patients with early-onset AF (the percentage was higher if diagnosed before the age of 30 years and lower if diagnosed after the age of 60 years). Most pathogenic/likely pathogenic variants are in genes associated with cardiomyopathy. These results support the use of genetic testing in early-onset AF.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jamacardio.2021.3370

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figure 1. The Comprehensive Arrhythmia and Cardiomyopathy Gene Panel Genes were selected from commercial panels. A total of 145 genes were included; 87 were included only on the cardiomyopathy gene panel, 36 only on the arrhythmia gene panel, and 22 on both.CC BY · PubMed Central

Figure 2. Results of Genetic Testing in Early-Onset Atrial Fibrillation (AF) for Genes Associated With Arrhythmia and Cardiomyopathy Syndromes Variants are classified according to standard American College of Medical Genetics and Genomics criteria. AD indicates autosomal dominant; AR, autosomal recessive; P/LP, pathogenic/likely pathogenic; VUS, variant of undetermined significance; XLD, X-linked dominant; XLR, X-linked recessive.CC BY · PubMed Central

Figure 3. Prevalence of Disease-Associated Variants and Genetic Overlap With Inherited Cardiomyopathy and Arrhythmia Syndromes A, Prevalence of disease-associated rare variants according to age at atrial fibrillation (AF) diagnosis presented by age groups. Error bars indicate bootstrapped 95% CIs. B, Prevalence of disease-associated rare variants presented as a continuous variable (cubic spline graph, P = .02 for the association between age and presence of disease-associated variant based on the F test). C, The genetic overlap between disease-associated variants and specific inherited cardiomyopathy and arrhythmia syndromes. Shaded in blue is the proportion of variants in major disease genes for each disorder. AC (ARVC) indicates arrhythmogenic cardiomyopathy (arrhythmogenic right ventricular cardiomyopathy); CPVT, catecholaminergic polymorphic ventricular tachycardia; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; LQTS, long QT syndrome.CC BY · PubMed Central

Figure 4. Breakdown According to the Most Prevalent Genes A, Pathogenic/likely pathogenic (P/LP) variants in autosomal dominant disorders. B, Variants of undetermined significance (VUSs); only loss-of-function variants in TTN are reported. C, Heterozygous P/LP variants in autosomal recessive (AR) disorders.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
Self-citation
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000040 · Cited by 2,056
Self-citation
HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes
Priori, S. G., Wilde, A. A., Horie, M., Cho, Y., Behr, E. R., Berul, C., Blom, N., Brugada, J., Chiang, C.-E., Huikuri, H., et al. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.05.014 · Cited by 1,942
ClinGen — The Clinical Genome Resource
Rehm, H. L., Berg, J. S., Brooks, L. D., Bustamante, C. D., Evans, J. P., Landrum, M. J., Ledbetter, D. H., Maglott, D. R., Martin, C. L., Nussbaum, R. L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmsr1406261 · Cited by 1,496
HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies
Ackerman, M. J., Priori, S. G., Willems, S., Berul, C. I., Brugada, R., Calkins, H. G., Camm, A. J., Ellinor, P. T., Gollob, M. H., Hamilton, R. M., et al. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.05.020 · Cited by 1,472
Self-citation
Mutations in the Cardiac Ryanodine Receptor Gene ( hRyR2 ) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia
Priori, S. G., Napolitano, C., Tiso, N., Memmi, M., Vignati, G., Bloise, R., Sorrentino, V., & Danieli, G. A. (2001) · Circulation · doi:10.1161/01.cir.103.2.196 · Cited by 1,378
Missense Mutations in the Rod Domain of the Lamin A/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System Disease
Fatkin, D., MacRae, C. A., Sasaki, T., Wolff, M. R., Porcu, M., Frenneaux, M. P., Atherton, J. J., Vidaillet, H. J., Jr., Spudich, S., Girolami, U. D., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412302 · Cited by 1,366
Clinical and Molecular Characterization of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
Priori, S. G., Napolitano, C., Memmi, M., Colombi, B., Drago, F., Gasparini, M., DeSimone, L., Coltorti, F., Bloise, R., Keegan, R., et al. (2002) · Circulation · doi:10.1161/01.cir.0000020013.73106.d8 · Cited by 1,163
Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
Dong, C., Wei, P., Jian, X., Gibbs, R. A., Boerwinkle, E., Wang, K., & Liu, X. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu733 · Cited by 1,151
KCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation
Chen, Y.-H., Xu, S.-J., Bendahhou, S., Wang, X.-L., Wang, Y., Xu, W.-Y., Jin, H., Sun, H., Su, X.-Y., Zhuang, Q.-N., et al. (2003) · Science · doi:10.1126/science.1077771 · Cited by 989
Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion
Tayoun, A. N. A., Pesaran, T. F., DiStefano, M. T., Oza, A. M., Rehm, H. L., Biesecker, L. G., Harrison, S. M., & ClinGen Sequence Variant Interpretation Working Group (ClinGen SVI) (2018) · Human Mutation · doi:10.1002/humu.23626 · Cited by 923
EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication
Goette, A., Kalman, J. M., Aguinaga, L., Akar, J. G., Cabrera, J. Á., Chen, S. A., Chugh, S. S., Corradi, D., d’Ávila, A., Dobrev, D., et al. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.05.028 · Cited by 791
Exome sequencing and characterization of 49,960 individuals in the UK Biobank
Van Hout, C. V., Tachmazidou, I., Backman, J. D., Hoffman, J. D., Liu, D., Pandey, A. K., Gonzaga-Jauregui, C., Khalid, S., Ye, B., Banerjee, N., et al. (2020) · Nature · doi:10.1038/s41586-020-2853-0 · Cited by 561
Sodium Channel Mutations and Susceptibility to Heart Failure and Atrial Fibrillation
Olson, T. M. (2005) · JAMA · doi:10.1001/jama.293.4.447 · Cited by 552
Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies
Ortiz-Genga, M., Cuenca, S., Ferro, M. D., Zorio, E., Salgado‐Aranda, R., Climent, V. E., Padrón-Barthe, L., Duro-Aguado, I., Jiménez‐Jáimez, J., Hidalgo-Olivares, V. M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.927 · Cited by 488
Genome-wide association study of PR interval
Pfeufer, A., van Noord, C., Marciante, K. D., Arking, D. E., Larson, M. G., Smith, A. V., Tarasov, K. V., Müller‐Nurasyid, M., Sotoodehnia, N., Sinner, M. F., et al. (2010) · Nature Genetics · doi:10.1038/ng.517 · Cited by 434
Self-citation
Several common variants modulate heart rate, PR interval and QRS duration
Hólm, H., Gudbjartsson, D. F., Arnar, D. O., Þorleifsson, G., Þorgeirsson, G., Stefansdottir, H., Gudjonsson, S. A., Jónasdóttir, Á., Mathiesen, E. B., Njølstad, I., et al. (2010) · Nature Genetics · doi:10.1038/ng.511 · Cited by 387
Actionable exomic incidental findings in 6503 participants: challenges of variant classificationPreprint
Amendola, L. M., Dorschner, M. O., Robertson, P. D., Salama, J. S., Hart, R., Shirts, B. H., Murray, M. L., Tokita, M., Gallego, C. J., Kim, D. S., et al. (2015) · Genome Research · doi:10.1101/gr.183483.114 · Cited by 371
Self-citation
Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction
Sotoodehnia, N., Isaacs, A. J., de Bakker, P. I. W., Dörr, M., Newton‐Cheh, C., Nolte, I. M., van der Harst, P., Müller‐Nurasyid, M., Eijgelsheim, M., Alonso, Á., et al. (2010) · Nature Genetics · doi:10.1038/ng.716 · Cited by 352
A rare variant in MYH6 is associated with high risk of sick sinus syndrome
Hólm, H., Gudbjartsson, D. F., Sulem, P., Másson, G., Helgadottir, H. T., Zanon, C., Magnússon, Ó. Þ., Helgason, A., Saemundsdottir, J., Gylfason, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.781 · Cited by 303
Self-citation
Targeted Mutational Analysis of the RyR2-Encoded Cardiac Ryanodine Receptor in Sudden Unexplained Death: A Molecular Autopsy of 49 Medical Examiner/Coroner's Cases
Tester, D. J., Spoon, D. B., Valdivia, H. H., Makielski, J. C., & Ackerman, M. J. (2004) · Mayo Clinic Proceedings · doi:10.4065/79.11.1380 · Cited by 294
Genetic variation in SCN10A influences cardiac conduction
Chambers, J. C., Zhao, J., Terracciano, C. M., Bezzina, C. R., Zhang, W., Kaba, R. A., Navaratnarajah, M., Lotlikar, A., Sehmi, J., Kooner, M. K., et al. (2010) · Nature Genetics · doi:10.1038/ng.516 · Cited by 287
Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy
Mazzarotto, F., Tayal, U., Buchan, R. J., Midwinter, W., Wilk, A., Whiffin, N., Govind, R., Mazaika, E., de Marvao, A., Dawes, T. J. W., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.037661 · Cited by 268
Association Between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation
Choi, S. H., Weng, L.-C. C., Roselli, C., Lin, H., Haggerty, C. M., Shoemaker, M. B., Barnard, J., Arking, D. E., Chasman, D. I., Albert, C. M., et al. (2018) · JAMA · doi:10.1001/jama.2018.18179 · Cited by 232
Self-citation
ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene‐level specification of the ACMG/AMP guidelines for sequence variant interpretation
Rivera-Munoz, E. A., Milko, L. V., Harrison, S. M., Azzariti, D. R., Kurtz, C. L., Lee, K., Mester, J. L., Weaver, M. A., Currey, E., Craigen, W. J., et al. (2018) · Human Mutation · doi:10.1002/humu.23645 · Cited by 214
Genetic variation in T-box binding element functionally affects SCN5A/SCN10A enhancer
van den Boogaard, M., Wong, L. Y. E., Tessadori, F., Bakker, M. L., Dreizehnter, L., Wakker, V., Bezzina, C. R., Hoen, P. A. C. ’., Bakkers, J., Barnett, P., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62613 · Cited by 203
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary
Towbin, J. A., McKenna, W. J., Abrams, D. J., Ackerman, M. J., Calkins, H. G., Darrieux, F., Daubert, J. P., de Chillou, C., DePasquale, E. C., Desai, M. Y., et al. (2019) · Heart Rhythm · doi:10.1016/j.hrthm.2019.09.019 · Cited by 197
A common genetic variant within SCN10A modulates cardiac SCN5A expression
van den Boogaard, M., Smemo, S., Burnicka-Turek, O., Arnolds, D. E., van de Werken, H. J. G., Klous, P., McKean, D. M., Muehlschlegel, J. D., Moosmann, J., Toka, O., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73140 · Cited by 192
Association of Arrhythmia-Related Genetic Variants With Phenotypes Documented in Electronic Medical Records
Van Driest, S. L., Wells, Q. S., Stallings, S., Bush, W. S., Gordon, A., Nickerson, D. A., Kim, J. H., Crosslin, D. R., Jarvik, G. P., Carrell, D. S., et al. (2016) · JAMA · doi:10.1001/jama.2015.17701 · Cited by 170
Self-citation
Monogenic and Polygenic Contributions to Atrial Fibrillation Risk
Choi, S. H., Jurgens, S. J., Weng, L.-C. C., Pirruccello, J. P., Roselli, C., Chaffin, M. D., Lee, C. J., Hall, A. W., Khera, A. V., Lunetta, K. L., et al. (2019) · Circulation Research · doi:10.1161/circresaha.119.315686 · Cited by 129
Self-citation
Frequency of genomic secondary findings among 21,915 eMERGE network participants
Gordon, A. S., Zouk, H., Venner, E., Eng, C. M., Funke, B., Amendola, L. M., Carrell, D., Chisholm, R. L., Chung, W. K., Denny, J. C., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0810-9 · Cited by 119
Self-citation
The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG)
Sinner, M. F., Pfeufer, A., Akyol, M., Beckmann, B.-M., Hinterseer, M., Wacker, A., Perz, S., Sauter, W., Illig, T., Näbauer, M., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehm619 · Cited by 107
Re-analysis of whole-exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases
Salfati, E., Spencer, E. G., Topol, S. E., Muse, E. D., Rueda, M., Lucas, J. R., Wagner, G. N., Campman, S. C., Topol, E. J., & Torkamani, A. (2019) · Genome Medicine · doi:10.1186/s13073-019-0702-2 · Cited by 90
A Missense Variant in PLEC Increases Risk of Atrial Fibrillation
Þórólfsdóttir, R. B., Sveinbjörnsson, G., Sulem, P., Helgadóttir, A., Grétarsdóttir, S., Benónísdóttir, S., Magnusdottir, A., Davidsson, O. B., Rajamani, S., Roden, D. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.005 · Cited by 77
Self-citation
Aggregate penetrance of genomic variants for actionable disorders in European and African Americans
Natarajan, P., Gold, N. B., Bick, A. G., McLaughlin, H. M., Kraft, P. L., Rehm, H. L., Peloso, G. M., Wilson, J. G., Correa, A., Seidman, J. G., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag2367 · Cited by 72
Association of Rare Genetic Variants and Early-Onset Atrial Fibrillation in Ethnic Minority Individuals
Chalazan, B., Mol, D., Darbar, F. A., Ornelas-Loredo, A., Al-Azzam, B., Chen, Y., Tofovic, D. S., Sridhar, A., Alzahrani, Z., Ellinor, P. T., et al. (2021) · JAMA Cardiology · doi:10.1001/jamacardio.2021.0994 · Cited by 63
Self-citation
Very early-onset lone atrial fibrillation patients have a high prevalence of rare variants in genes previously associated with atrial fibrillation
OLESEN, M. S., Andreasen, L., Jabbari, J., Refsgaard, L., Haunsø, S., Olesen, S., Nielsen, J. B., Schmitt, N., & Svendsen, J. H. (2013) · Heart Rhythm · doi:10.1016/j.hrthm.2013.10.034 · Cited by 61
Broad Genetic Testing in a Clinical Setting Uncovers a High Prevalence of Titin Loss-of-Function Variants in Very Early Onset Atrial Fibrillation
Goodyer, W. R., Dunn, K. E., Caleshu, C. A., Jackson, M., Wylie, J., Moscarello, T., Platt, J., Reuter, C. M., Smith, A., Trela, A. V., et al. (2019) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.119.002713 · Cited by 60
A novel mutation in LAMIN A/C is associated with isolated early-onset atrial fibrillation and progressive atrioventricular block followed by cardiomyopathy and sudden cardiac death
Pan, H., Richards, A. A., Zhu, X., Joglar, J. A., Yin, H. L., & Garg, V. (2009) · Heart Rhythm · doi:10.1016/j.hrthm.2009.01.037 · Cited by 57
Relevance of Titin Missense and Non-Frameshifting Insertions/Deletions Variants in Dilated Cardiomyopathy
Akinrinade, O., Heliö, T. M., Deprez, R. H. L., Jongbloed, J. D. H., Boven, L. G., van den Berg, M. P., Pinto, Y. M., Alastalo, T., Myllykangas, S., van Spaendonck‐Zwarts, K. Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-39911-x · Cited by 57
Actionable secondary findings from whole-genome sequencing of 954 East Asians
Tang, C. S.-M., Dattani, S., So, M., Cherny, S. S., Tam, P. K. H., Sham, P. C., & García-Barceló, M.-M. (2017) · Human Genetics · doi:10.1007/s00439-017-1852-1 · Cited by 54
4258Re-evaluating the genetic contribution of monogenic dilated cardiomyopathy
Mazzarotto, F., Tayal, U., Buchan, R. J., Midwinter, W., Wilk, A., Whiffin, N., Watkins, H. C., Funke, B., O’Regan, D. P., Olivotto, I., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz745.0136 · Cited by 51
Common Coding Variants in SCN10A Are Associated With the Nav1.8 Late Current and Cardiac Conduction
Macri, V., Brody, J. A., Arking, D. E., Hucker, W. J., Yin, X., Lin, H., Mills, R. W., Sinner, M. F., Lubitz, S. A., Liu, C., et al. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.116.001663 · Cited by 32
Self-citation
Enrichment of loss-of-function and copy number variants in ventricular cardiomyopathy genes in ‘lone’ atrial fibrillation
Lazarte, J., Laksman, Z., Wang, J., Robinson, J. F., Dron, J. S., Leach, E., Liew, J., McIntyre, A. D., Skanes, A. C., Gula, L. J., et al. (2020) · EP Europace · doi:10.1093/europace/euaa421 · Cited by 28
How Will Genetics Inform the Clinical Care of Atrial Fibrillation?
Shoemaker, M. B., Shah, R. L., Roden, D. M., & Perez, M. V. (2020) · Circulation Research · doi:10.1161/circresaha.120.316365 · Cited by 27
Self-citation
Incidental and clinically actionable genetic variants in 1005 whole exomes and genomes from Qatar
Jain, A. K., Gandhi, S., Koshy, R., & Scaria, V. (2018) · Molecular Genetics and Genomics · doi:10.1007/s00438-018-1431-8 · Cited by 27
Epidemiology and clinical characteristics of atrial fibrillation in patients with inherited heart diseases
Butters, A., Isbister, J. C., MEDI, C., Raju, H., Turner, C., Sy, R. W., Semsarian, C., & Ingles, J. (2020) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14346 · Cited by 18
Genetic Testing for Early Onset Atrial Arrhythmias Changes Clinical Management
Yoneda, Z. T., Anderson, K. C., Estrada, J. C., Quintana, J. A., Strickland, T. L., Montgomery, J. A., Michaud, G. F., Roden, D. M., & Shoemaker, M. B. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.11.006 · Cited by 4
Self-citation

Sorted by citations

Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 3,145
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z., Anderson, C. A. M., Arora, P. K., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,284
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933

See all 192

Authors: Yoneda, Z. T., Anderson, K. C., Quintana, J. A., O’Neill, M. J., Sims, R. A., Glazer, A. M., Shaffer, C. M., Crawford, D. M., Stricker, T., Ye, F., Wells, Q., Stevenson, L. W., Michaud, G. F., Darbar, D., Lubitz, S. A., Ellinor, P. T., Roden, D. M., & Shoemaker, M. B.
Affiliations: Vanderbilt University Medical Center (US)
Vanderbilt University (US)
University of Illinois Chicago (US)
Broad Institute (US)
Corresponding author: Shoemaker, M. Benjamin
ORCID: Yoneda, Zachary T.
Anderson, Katherine C.
O’Neill, Matthew J.
Glazer, Andrew M.
Crawford, Diane M.
Stricker, Thomas
Ye, Fei
Wells, Quinn
Stevenson, Lynne W.
Michaud, Gregory F.
Darbar, Dawood
Lubitz, Steven A.
Ellinor, Patrick T.
Roden, Dan M.
Shoemaker, M. Benjamin
Venue: JAMA Cardiology
Publisher: American Medical Association (AMA)
Published: 2021-12-01
Volume: 6
Issue: 12
Pages: 1371
ISSN: 2380-6583 (ISSN-L)
DOI: 10.1001/jamacardio.2021.3370
PMC: PMC8427496
OpenAlex: W3196904047
Cited by: 192
References: 51
Citations by year: 2026: 46 · 2025: 42 · 2024: 43 · 2023: 32 · 2022: 28 · 2021: 1
FWCI: 17.43
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
Locations: JAMA Cardiology (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Funders: American Heart Association (18SFRN34110082)
National Institutes of Health (UL1TR002243)
National Heart, Lung, and Blood Institute (R01HL140074, K24HL105780, R01HL155197)
National Human Genome Research Institute (K99HG010904)
National Institute of General Medical Sciences (T32GM007347, T32GM152284)
National Center for Advancing Translational Sciences
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
Keywords: early-onset atrial fibrillation, rare variants, familial cardiomyopathy, inherited arrhythmia, genetic testing, variant interpretation, autosomal recessive disorder, whole genome sequencing, pathogenic variants, genetic counseling
MeSH terms: Whole Genome Sequencing, Adult, Aged, Atrial Fibrillation, Female, Follow-Up Studies, Humans, Male, Middle Aged, Cardiomyopathies, Prospective Studies, Registries, United States, Prevalence, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Early-Onset Atrial Fibrillation and the Prevalence of Rare Variants in Cardiomyopathy and Arrhythmia Genes

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks